NovoCure (NVCR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

NovoCure (NVCR) reported $154.99 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 11.9%. EPS of -$0.31 for the same period compares to -$0.36 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $147.57 million, representing a surprise of +5.03%. The company delivered an EPS surprise of +34.04%, with the consensus EPS estimate being -$0.47.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- a ...